Propafenone

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C21H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 68IQX3T69U, chemically known as 1-propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl- but more generally known as propafenone, which bears US NIH Compound Identifier 4932. European Medicines Agency schedules Propafenone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10094MIG. The term PROPAFENONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules propafenone in its Anatomical Therapeutic Chemical (ATC) Classification. PROPAFENONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule propafenone under HS 29221980 and SITC 51461. As of Q4 2014, PROPAFENONE remains US FDA's Preferred Term for this commodity. Propafenone bears US NLM identifiers UMLS ID C0033429 and NCI Concept Code C61909. SMILES: O(CC(O)CNCCC)C1C(C(=O)CCC2CCCCC2)CCCC1.